Keene & Associates’s Walgreens Boots Alliance WBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-88,910
Closed -$1.98M 82
2023
Q3
$1.98M Buy
88,910
+4,255
+5% +$113K 1.59% 31
2023
Q2
$2.41M Buy
84,655
+1,144
+1% +$37.3K 1.87% 29
2023
Q1
$2.89M Buy
83,511
+49,180
+143% +$1.75M 2.24% 27
2022
Q4
$1.28M Sell
34,331
-34,201
-50% -$1.29M 1.15% 30
2022
Q3
$2.15M Buy
68,532
+5,149
+8% +$191K 1.98% 29
2022
Q2
$2.4M Buy
63,383
+566
+0.9% +$24.3K 2.25% 28
2022
Q1
$2.81M Buy
62,817
+6,082
+11% +$299K 2.29% 29
2021
Q4
$2.96M Buy
+56,735
New +$2.75M 2.56% 18

Other funds holding WBA

Keene & Associates's WBA Position: Q4 2023 in Review

Keene & Associates sold out of Walgreens Boots Alliance (WBA) in Q4 2023, closing a stake of 88,910 shares — an estimated $1.98M sold.

Keene & Associates first reported a position in WBA in Q4 2021 and held it in 8 quarters. The position peaked at $2.96M in Q4 2021. 1,071 funds tracked by Wall St. Rank hold WBA as of Q4 2023.

  • Keene & Associates reported no remaining Walgreens Boots Alliance position as of Q4 2023 after selling out during the quarter.
  • Keene & Associates sold 88,910 Walgreens Boots Alliance shares in Q4 2023, an estimated $1.98M.
  • Keene & Associates first reported a position in Walgreens Boots Alliance in Q4 2021 and held it in 8 quarters.
  • Keene & Associates's Walgreens Boots Alliance position peaked at $2.96M in Q4 2021.
  • 1,071 funds tracked by Wall St. Rank held Walgreens Boots Alliance as of Q4 2023.

Based on Keene & Associates's 13F filing for Q4 2023, filed 30 Jan 2024.